ReviewOncoTargets and therapy2022

Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab.

Ryan S Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.